Literature DB >> 25347005

Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma.

H Ariizumi1, B Saito1, Y Uto1, N Hattori1, H Nakashima1, K Yanagisawa1, H Harada1, H Mori1, T Nakamaki1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25347005     DOI： 10.1038/bmt.2014.236

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

Review 1.  Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Authors:  B D Cheson; S J Horning; B Coiffier; M A Shipp; R I Fisher; J M Connors; T A Lister; J Vose; A Grillo-López; A Hagenbeek; F Cabanillas; D Klippensten; W Hiddemann; R Castellino; N L Harris; J O Armitage; W Carter; R Hoppe; G P Canellos
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

Review 2.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.

Authors:  Denise M Oliansky; Myron Czuczman; Richard I Fisher; Frank D Irwin; Hillard M Lazarus; James Omel; Julie Vose; Steven N Wolff; Roy B Jones; Philip L McCarthy; Theresa Hahn
Journal:  Biol Blood Marrow Transplant       Date:  2010-07-23       Impact factor: 5.742

3.  Peripheral blood stem cell transplantation in patients over 65 years old with malignant lymphoma--possibility of early completion of chemotherapy and improvement of performance status.

Authors:  M Tabata; K Kodama; T Matsuo
Journal:  Intern Med       Date:  2001-06       Impact factor: 1.271

4.  Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.

Authors:  A Numata; T Miyamoto; Y Ohno; T Kamimura; K Kamezaki; T Tanimoto; K Takase; H Henzan; K Kato; K Takenaka; T Fukuda; N Harada; K Nagafuji; T Teshima; K Akashi; M Harada; T Eto
Journal:  Bone Marrow Transplant       Date:  2009-07-13       Impact factor: 5.483

5.  FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.

Authors:  Masahiro Okada; Norihide Sato; Kazunari Ishii; Kaname Matsumura; Makoto Hosono; Takamichi Murakami
Journal:  Radiographics       Date:  2010 Jul-Aug       Impact factor: 5.333

Review 6.  [Autologous blood stem cell transplantation-current status and issues. Fukuoka Bone Marrow Transplantation Group].

Authors:  K Nagafuji; M Harada
Journal:  Rinsho Ketsueki       Date:  1995-06

7.  Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.

Authors:  Kelley Salem; Charles O Brown; Jeanine Schibler; Apollina Goel
Journal:  Exp Hematol       Date:  2012-10-11       Impact factor: 3.084

8.  SIL index, comprising stage, soluble interleukin-2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B-cell lymphoma.

Authors:  Naoto Tomita; Rika Sakai; Shin Fujisawa; Katsumichi Fujimaki; Jun Taguchi; Chizuko Hashimoto; Koji Ogawa; Etsuko Yamazaki; Yoshiaki Ishigatsubo
Journal:  Cancer Sci       Date:  2012-07-04       Impact factor: 6.716

Review 9.  Impact of interleukin-6 in hematological malignancies.

Authors:  Renate Burger
Journal:  Transfus Med Hemother       Date:  2013-07-19       Impact factor: 3.747

10.  Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma.

Authors:  Yoshihiro Kameoka; Naoto Takahashi; Kenichi Ishizawa; Yuichi Kato; Jugo Ito; Osamu Sasaki; Kazunori Murai; Hideyoshi Noji; Makoto Hirokawa; Katsusi Tajima; Tsutomu Shichishima; Yoji Ishida; Hideo Harigae; Kenichi Sawada
Journal:  Int J Hematol       Date:  2012-10-01       Impact factor: 2.319
View more
  2 in total

1.  Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

Authors:  M Gupta; M Stenson; M O'Byrne; M J Maurer; T Habermann; J R Cerhan; G W Weiner; T E Witzig
Journal:  Ann Oncol       Date:  2015-10-20       Impact factor: 32.976

2.  The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016.

Authors:  Mattias Carlsten; Martin Jädersten; Anna Hellström; Karin Littmann; Christopher M Melén; Henna Riikka Junlén; Kristina Sonnevi; Per Ljungman; Bo Björkstrand; Björn Engelbrekt Wahlin
Journal:  Exp Hematol Oncol       Date:  2019-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.